 |
PDBsum entry 4hmh
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Screening and structural analysis of flavones inhibiting tankyrases.
|
 |
|
Authors
|
 |
M.Narwal,
T.Haikarainen,
A.Fallarero,
P.M.Vuorela,
L.Lehtiö.
|
 |
|
Ref.
|
 |
J Med Chem, 2013,
56,
3507-3517.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
|
Note: In the PDB file this reference is
annotated as "TO BE PUBLISHED". The citation details given above have
been manually determined.
|
 |
 |
|
Abstract
|
 |
|
Flavonoids are known for their beneficial effects on human health, and therefore
the therapeutic potential of these compounds have been extensively studied.
Flavone has been previously identified as a tankyrase inhibitor, and to further
elucidate whether tankyrases would be inhibited by other flavonoids, we
performed a systematic screening of tankyrase 2 inhibitory activity using 500
natural and naturally derived flavonoids covering nine different flavonoid
classes. All identified tankyrase inhibitors were flavones. We report crystal
structures of all the hit compounds in complex with the catalytic domain of
human tankyrase 2. Flavone derivatives in all 10 crystal structures bind to the
nicotinamide binding site of tankyrase 2. Potencies of the active flavones
toward tankyrases vary between 50 nM and 1.1 μM, and flavones show up to
200-fold selectivity for tankyrases over ARTD1. The molecular details of the
interactions revealed by cocrystal structures efficiently describe the
properties of potent flavone derivatives inhibiting tankyrases.
|
 |
|
|
|
|
 |